This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs ...
The Towards a Revolution in COPD Health (TORCH) trial evaluated the effect of treatments for chronic obstructive pulmonary disease (COPD) on morbidity and mortality outcomes. The study randomized ...
Of the 435 patients recruited, 349 were randomised to treatment: 176 patients to the salmeterol/FP group and 173 to the BUD group. Of the 86 withdrawn before randomisation, 66 failed to fulfil the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results